Distribution of HCV Genotypes in the Populations of Inmates in Polish Prison Potulice and Patients Hospitalised in Bydgoszcz

Authors Information
Article Notes and Dates
To Cite : Tyczyno M, Halota W, Nowak W, Pawlowska M. Distribution of HCV Genotypes in the Populations of Inmates in Polish Prison Potulice and Patients Hospitalised in Bydgoszcz, Hepat Mon. 2014 ;14(5):e14559. doi: 10.5812/hepatmon.14559.
Copyright: Copyright © 2014, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci. 2006; 3(2): 41-6[PubMed]
  • 2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. The Lancet Infectious Diseases. 2005; 5(9): 558-67
  • 3. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev. 2000; 13(2): 223-35[PubMed]
  • 4. Fattovich G, Ribero ML, Pantalena M, Diodati G, Almasio P, Nevens F, et al. Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe. J Viral Hepat. 2001; 8(3): 206-16[PubMed]
  • 5. Singh B, Verma M, Verma K. Markers for transfussion-associaced hepatitis in north Indian blood donors: prevalence and trends. Jpn I Infect Dis. 2004; 57(2): 49-51
  • 6. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis. 2008; 8: 69[DOI][PubMed]
  • 7. Nguyen MH, Keeffe EB. Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2005; 3
  • 8. Ramia S, Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis. 2006; 10(4): 272-7[DOI][PubMed]
  • 9. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001; 345(1): 41-52[DOI][PubMed]
  • 10. Meyer MF, Wedemeyer H, Monazahian M, Dreesman J, Manns MP, Lehmann M. Prevalence of hepatitis C in a German prison for young men in relation to country of birth. Epidemiol Infect. 2007; 135(2): 274-80[DOI][PubMed]
  • 11. Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, et al. Characteristics of patients with dual infection by hepatitis B and C viruses. Journal of Hepatology.; 28(1): 27-33[DOI]
  • 12. Stroffolini T, D'Egidio PF, Aceti A, Filippini P, Puoti M, Leonardi C, et al. Hepatitis C virus infection among drug addicts in Italy. J Med Virol. 2012; 84(10): 1608-12[DOI][PubMed]
  • 13. Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health. 2000; 3(2): 121-6[PubMed]
  • 14. Skipper C, Guy JM, Parkes J, Roderick P, Rosenberg WM. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy. Gut. 2003; 52(10): 1500-4[PubMed]
  • 15. Kassaian N, Adibi P. Hepatitis C virus and associated risk factors among prison inmates with history of drug injection in Isfahan, Iran. Int J Prev Med. 2012; 3: 165-1
  • 16. Vallabhaneni S, Macalino GE, Reinert SE, Schwartzapfel B, Wolf FA, Rich JD. Prisoners favour hepatitis C testing and treatment. Epidemiol Infect. 2006; 134(2): 243-8[DOI][PubMed]
  • 17. Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ. 2000; 321(7253): 78-82[PubMed]
  • 18. Murcia J, Portilla J, Bedia M, Palazon JM, Sanchez-Paya J, Saiz de la Hoya P, et al. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison]. Enferm Infecc Microbiol Clin. 2009; 27(4): 206-12[DOI][PubMed]
  • 19. Farley JD, Wong VK, Chung HV, Lim E, Walters G, Farley TA, et al. Treatment of chronic hepatitis C in Canadian prison inmates. Can J Gastroenterol. 2005; 19(3): 153-6[PubMed]
  • 20. Santos BF, de Santana NO, Franca AV. Prevalence, genotypes and factors associated with HCV infection among prisoners in Northeastern Brazil. World J Gastroenterol. 2011; 17(25): 3027-34[DOI][PubMed]
  • 21. Tyczyno M. HCV genotypes among patients diagnosed in Bydgoszcz. MSR Hepatol. 2007; 7: 77-9
  • 22. Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, et al. Changing HCV genotypes distribution in Poland--relation to source and time of infection. J Clin Virol. 2008; 42(2): 156-9[DOI][PubMed]
  • 23. Januszkiewicz-Lewandowska D, Wysocki J, Rembowska J, Pernak M, Lewandowski K, Nowak T, et al. Transmission of HCV infection among long-term hospitalized onco-haematological patients. J Hosp Infect. 2003; 53(2): 120-3[PubMed]
  • 24. Touceda S, Pereira M, Agulla A. Prevalence of hepatitis C virus genotype in the areao of El Ferrol (La Coruna, Spain). . Enferm Infecc Microbiol Clin. 2002; 20(5): 200-4
  • 25. Grabczewska E, Pawlowska M, Halota W. Epidemiological aspects of HCV-HIV co-infections. HIV AIDS Rev. 2003; 2: 123-6
  • 26. Babik JM, Holodniy M. Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients. J Virol. 2003; 77(3): 1940-50[PubMed]
  • 27. Krekulova L, Rehak V, Madrigal N. Genotypic and epidemiologic characteristics of hepatitis C virus infection among recent injection drug users and nonusers populations. Clin Infect Dis. 2001; 15(8): 1435-8
  • 28. Poveda E, Vispo E, Barreiro P, de Mendoza C, Labarga P, Fernandez-Montero JV, et al. Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in Spain. Antivir Ther. 2012; 17(3): 571-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check